In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.
--------
Question: Amends Federal transportation law to establish a National Transportation System (NTS) that will move people and goods in a way that promotes mobility, economic productivity, congestion relief, energy conservation, and air quality improvement. 
Directs the Secretary of Transportation to submit to the Congress the designation of the NTS.  Prohibits proposed new routes or facilities that are in nonattainment areas for ozone or carbon monoxide, or segments of the National Highway System (NHS), from being included in the NTS until they have been included in a metropolitan or State long-range plan transportation improvement program conforming to a State implementation plan developed pursuant to the Clean Air Act.  Authorizes the Secretary to make grants to pay 80 percent of the development and implementation costs of the NTS. 
Requires a metropolitan or State long-range plan to identify, at a minimum, transportation facilities, including, among others, airport, port, inland waterway, and railroad, that function as an integrated metropolitan or State transportation system, giving emphasis to facilities that serve important national and regional transportation functions.  Requires such transportation systems to serve as the NTS in such metropolitan area or State, unless the Secretary determines it would not be in the public interest or promote the goals of the NTS.  Directs the Secretary to set-aside a specified percentage of NHS funds for grants for the developmental costs of the NTS. 
Directs States to set-aside a specified percentage of their NHS apportionment to provide intermodal connections to the NHS or connections between the NHS and the NTS.  Prohibits the use of State set-asides for projects that add new capacity for single-occupant passenger vehicles (other than for facilities which are part of a system that reduces their use).  Sets forth formulae for the apportionment of NHS funds to certain urbanized and rural areas.

Answer: To amend title 23, United States Code, relating to establishment of the National Transportation System.


Question: Ethanol Infrastructure Expansion Act of 2006 - Directs the Secretary of Energy, in coordination with the Secretary of Agriculture and the Secretary of Transportation, to award up to $1 million to one or more eligible firms to conduct feasibility studies for the construction of one or more dedicated ethanol pipelines.

Answer: A bill to require the Secretary of Energy to award funds to study the feasibility of constructing 1 or more dedicated ethanol pipelines to increase the energy, economic, and environmental security of the United States, and for other purposes.


Question: Ethical Pathway Act of 2012 - Directs the Commissioner of Food and Drugs (FDA) to establish a mechanism by which an applicant to sell any new pharmaceutical drug, vaccine, biologic product, or medical device that requires regulatory approval by the Secretary of Health and Human Services (HHS) (regulated product) may request a cost-sharing arrangement under which the applicant shall: (1) verify that intended clinical investigations involving humans or vertebrate animals have not been performed or initiated by another person; (2) make reasonable efforts to obtain voluntary agreements to use existing evidence regarding the safety and efficacy of new pharmaceutical drugs or biological products used to obtain marketing approval for use in humans or vertebrate animals (regulatory test data); and (3) notify the Commissioner if there is a failure to reach a voluntary agreement, at which point the Commissioner shall ask the parties to agree to binding arbitration to determine the reasonable and fair fee for relying upon relevant regulatory test data.

Permits such applicant to request such arrangement if, but for the arrangement: (1) the applicant would be required to conduct clinical investigations involving human subjects that violate Article 20 of the Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects in order to obtain regulatory approval of the regulated product, or (2) the duplication of the clinical investigations required for such application would violate other applicable ethical standards concerning the testing of products on humans or other vertebrate animals.

Requires the fee for reliance by the applicant on such regulatory test data to be determined after considering: (1) the actual out-of-pocket costs of the applicable clinical investigations; (2) the risks of the investigations; (3) any federal grants, tax credits, or other subsidies; (4) the expected share of the global market for the product involved; and (5) the amount of time the holders of the relevant applications or licenses have benefited from exclusive rights and the cumulative revenue earned on the products that relied upon the data at issue. Directs the Secretary to adopt procedures and rules under which sufficient information about costs and fees will be made public.

Answer:
A bill to eliminate requirements to undertake duplicative clinical testing of new pharmaceutical drugs, vaccines, biological products, or medical devices, when such duplication is inconsistent with relevant ethical norms.